¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"clinical spectroscopy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nuclear magnetic resonance spectroscopy
    ÇÙÀÚ±â°ø¸íºÐ±¤¹ý
  • spectroscopy
    1. ºÐ±¤ÇÐ 2. ºÐ±¤¹ý
  • clinical
    Áø·á-, ÀÓ»ó-
  • clinical algorithm
    ÀÓ»óÀû¾Ë°í¸®µë
  • clinical chart
    º´·ÂÁö
  • clinical crib
    1. ÀÓ»ó¿ëÀ¯¾ÆÄ§´ë 2. ÀÓ»ó¿ë°Ý»ó±³Á¤ÀåÄ¡
  • clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®, ÀÓ»óÄ¡¾Æ°ü
  • clinical cytogenetics
    Àӻ󼼯÷À¯ÀüÇÐ
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clinical dementia rating scale
    ÀÓ»óÄ¡¸ÅÆò°¡Ã´µµ
  • clinical diagnosis
    ÀÓ»óÁø´Ü
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • clinical epidemiologist
    ÀÓ»ó¿ªÇÐÀÚ
  • clinical epidemiology
    ÀÓ»ó¿ªÇÐ
  • clinical finding
    ÀÓ»ó¼Ò°ß
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical
    Áø·á-. ÀÓ»ó-
  • objective structured clinical (OSCE) examination
    °´°ü±¸Á¶È­Áø·á½ÃÇè
  • clinical manifestation
    ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
  • clinical trial
    ÀÓ»ó½ÃÇè
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • depth resolved surface coil spectroscopy
    ±íÀÌÇØ°áÇ¥¸éÄÚÀϺб¤¹ý
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
  • image selected iv vivo spectroscopy
    ¿µ»ó¼±ÅûýüºÐ±¤¹ý
  • magnetic resonance spectroscopy
    ÀÚ±â°ø¸íºÐ±¤¹ý
  • nuclear magnetic resonance spectroscopy
    ÇÙÀÚ±â°ø¸íºÐ±¤¹ý
  • spectroscopy
    ºÐ±¤¹ý
  • stimulated echo spectroscopy
    Àڱظ޾Ƹ®ºÐ±¤¹ý
  • clinical algorithm
    ÀÓ»óÀû³í¸®Ã¼°è
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clinical
    ÀÓ»ó-
  • clinical chart
    º´»óÀÏÁö
  • clinical crib
    ÀÓ»ó¿ëÀ¯¾ÆÄ§´ë, ÀÓ»ó¿ë°Ý»ó±³Á¤ÀåÄ¡
  • clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®, ÀÓ»óÄ¡¾Æ°ü
  • clinical data
    ÀÓ»óÀÚ·á
  • clinical diagnosis
    ÀÓ»óÁø´Ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MR spectroscopy
    MR ºÐ±¤¹ý
  • P-31 NMR spectroscopy
    P-31 ÀÚ±â°ø¸í ºÐ±¤¹ý(¼ú)
  • image selected in vivo spectroscopy (ISIS)
    ¿µ»ó ¼±Åà »ýü ºÐ±¤¹ý
  • Clinical data
    ÀÓ»óÀÚ·á
  • Clinical skills
    ÀÓ»ó¼ú±â
  • GCP : good clinical practice
    ÀÓ»ó½ÃÇè °ü¸®±âÁØ.
  • Good Clinical Practice(GCP)
    ÀǾàǰ ÀÓ»ó½ÃÇè °ü¸®±âÁØ
  • SCAG, Sandoz Clinical Assessment-Geriatric
    »êµµ½º ³ëÀÎÀÓ»óÆò°¡(-ôµµ)
  • SCAN, Schedule for Clinical Assessment in Neuropsychaitry
    ½Å°æÁ¤½Å°ú¿¡ ÀÖ¾î ÀÓ»óÆò°¡¸¦ À§ÇÑ ¸ñ·Ï
  • randomized clinical trial
    ¹«ÀÛÀ§ÀÓ»ó½ÇÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atomic absorption spectroscopy
    ¿øÀÚÈí±¤ ºÐ±¤ºÐ¼®¹ý(¡­ÝÂÎÃÝÂà°Ûö).
  • depth resolved surface coil spectroscopy (DRESS)
    ±íÀÌ ÇØ°á Ç¥¸é ÄÚÀÏ ºÐ±¤¹ý
  • diffusion spectroscopy
    È®»ê ºÐ±¤¹ý
  • image selected in vivo spectroscopy (ISIS)
    ¿µ»ó ¼±Åà »ýü ºÐ±¤¹ý
  • magnetic resonance (MR) spectroscopy
    ÀÚ±â°ø¸íºÐ±¤¹ý
  • magnetic resonance spectroscopy
    ÀÚ±â°ø¸í¿µ»óºÐ±¤°æ°Ë»ç
  • magnetic resonance spectroscopy(MRS)
    ÀÚ±â°ø¸íºÐ±¤°Ë»ç(í¸Ñ¨ÍìÙ°ÝÂÎÃËþÞÛ)
  • mass spectroscopy with gas
    °¡½ºÁú·®ÃøÁ¤¹ý
  • proton MR spectroscopy
  • spectroscopy
    ºÐ±¤¹ý(¼ú)
  • spectroscopy
    ºÐ±¤°æ°Ë»ç¹ý
  • stimulated echo spectroscopy
    ÀÚ±Ø ¿¡ÄÚ ºÐ±¤¹ý
  • bacteriology, clinical
    ÀÓ»ó¼¼±ÕÇÐ
  • clinical application
    ÀÓ»óÀûÀÀ¿ë<--Àû¿ë>
  • clinical bacteriology
    ÀÓ»ó¼¼±ÕÇÐ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®
    [¿¾ ¿ë¾î] ÀÓ»óÄ¡°ü
  • Clinical root
    ÀÓ»óÄ¡¾Æ»Ñ¸®
    [¿¾ ¿ë¾î] ÀÓ»óÄ¡±Ù
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical parasitology
    ÀÓ»ó±â»ýÃæÇÐ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fluctuation spectroscopy
    ¿äµ¿ ºÐ±¤±¤µµ¹ý(èôÔÑÝÂÎÃÎÃÓøÛö)
  • Fourier transform infrared spectroscopy
    Ǫ¸®¿¡ º¯È¯(ܨüµ) Àû¿Ü¼±ºÐ±¤±¤µµ¹ý(îåèâàÊÝÂÎÃÎÃÓøÛö)
  • reflection-absorption infrared spectroscopy
    ¹Ý»çÈí¼ö Àû¿Ü¼± ºÐ±¤±¤µµ°è (ÚãÞÒýåâ¥îåèâàÊÝÂÎÃÎÃÓøÍª)
  • resonance Raman spectroscopy
    °ø¸í ¶ó¸¸ ºÐ±¤¹ý(ÝÂÎÃÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical application
    ÀÓ»óÀû¿ë
  • depth resolved surface coil spectroscopy [=DRESS]
    ±íÀÌÇØ°áÇ¥¸éÄÚÀϺб¤¹ý
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
  • image selected in vivo spectroscopy [=ISIS]
    ¿µ»ó¼±ÅûýüºÐ±¤¹ý
  • magnetic resonance [=MR] spectroscopy
    ÀÚ±â°ø¸íºÐ±¤¹ý
  • P-31 NMR spectroscopy
    P-31ÀÚ±â°ø¸íºÐ±¤¹ý(¼ú)
  • proton MR spectroscopy
    ¾çÀÚÀÚ±â°ø¸íºÐ±¤¼ú
  • spectroscopy
    ºÐ±¤¹ý(¼ú)
  • stimulated echo spectroscopy
    Àڱؿ¡Äںб¤¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
ACCP American College of Chest Physicians; American College of Clinical Pharmacology; American College of...
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CIS carcinoma in situ; catheter-induced spasm; central inhibitory state; Chemical Information Service; c...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(1)H MRS 1)H magnetic resonance spectroscopy
MRS 1)H-magnetic resonance spectroscopy
(31)P-MRS 31)P magnetic resonance spectroscopy
MRS 31)P-magnetic resonance spectroscopy
31P-MRS 31-Phosphorus magnetic resonance spectroscopy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atomic absorption spectroscopy
    ¿øÀÚ Èí±¤ ºÐ±¤ ºÐ¼®
  • image selected in vivo spectroscopy
    ¿µ»ó ¼±Åà »ýü ºÐ±¤¹ý
  • P-31 NMR spectroscopy
    P-31 Àڱ⠰ø¸í ºÐ±¤¹ý, P-31 Àڱ⠰ø¸í ºÐ±¤¼ú
  • temporal spectroscopy
    ¼ø°£ ºÐ±¤ ºÐ¼®±â
  • clinical application
    ÀÓ»óÀû Àû¿ë
  • clinical chart
    º´»ó ÀÏÁö
  • clinical cytogenetics
    ¼¼Æ÷ À¯ÀüÇÐ
    À¯Àü, Áï ¿°»öü¿Í °ü°èµÈ ¼¼Æ÷ ¿ä¼Ò¸¦ ¿¬±¸ÇÏ´Â À¯ÀüÇÐÀÇ ºÐ¾ß.
  • clinical diagnosis
    ÀÓ»ó Áø´Ü, ÀÓ»óÀû Áø´Ü
    Áø´ÜÀº º¸Åë º´·ÂÀ» ûÃëÇÏ°í ½ÅüÀû ¼Ò°ßÀ» ÃëÇϸç Çʿ信 µû¶ó¼­ °Ë»çÇÏ°í ¾òÀº Á¤º¸¸¦ Á¾ÇÕÇØ¼­ ³»·ÁÁö´Â °ÍÀ¸·Î ÀÌ¿Í °°Àº Áø´ÜÀ» ¼ö¼ú ½Ã¿¡ È®ÀÎÇÑ ¼ö¼ú½Ã Áø´Ü, ¶Ç´Â »çÈÄ ºÎ°Ë¿¡ ÀÇÇØ¼­ È®ÀÎµÈ º´¸® Áø´ÜÀ» ´ëºñ½ÃÄѼ­ ÀÓ»ó Áø´ÜÀ̶ó°í ÇÑ´Ù.
  • clinical examination
    ÀÓ»ó °Ë»ç, ÀÓ»ó ÁøÂû, ÀÓ»óÀû °üÂû
  • clinical hematology
    ÀÓ»ó Ç÷¾×ÇÐ
  • clinical interview
    ÀÓ»ó ¸é´ã
  • clinical locking
    ÀÓ»óÀû °úµÎ °É¸²
  • clinical material
    ÀÓ»ó °¡°Ë¹°, ÀÓ»ó °Ëü
  • clinical modification code
    ÀÓ»ó ¼öÁ¤ ºÎÈ£
  • clinical pharmacology
    ÀÓ»ó ¾à¸®ÇÐ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
clinical spectroscopy Spectroscopic examination of specimens of living tissue, including fluids removed therefrom.
Synonym: clinical spectroscopy.
Origin: bio-+ L. Spectrum, image, + G. Skopeo, to examine
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absorption spectroscopy <investigation> This is the use of a spectrophotometer to measure the ability of particles (solutes) in a solution to absorb light through a range of specific wavelengths.
Every compound absorbs light differently, so absorption spectra can be used to identify compounds, measure concentrations, and determine reaction rates.
(15 Jan 1998)
magnetic resonance spectroscopy Detection and measurement of the resonant spectra of molecular species in a tissue or sample.
(05 Mar 2000)
Parallel Electron Energy Loss Spectroscopy <technique> Electron energy loss spectroscopy analyses the inelastically scattered electrons present in the beam after it has been transmitted through the sample. An electron energy loss spectrum typically consists of a monatomic decreasing background on which are superimposed a number of peaks. Each peak is characteristic of the scattering process that has occurred in the sample. The peaks can be used to obtain information about the chemical composition and electronic structure of the sample. Electron energy loss spectra are acquired typically in a magnetic sector spectrometer located under the camera chamber of the transmission electron microscope. Spatial resolution is typically limited by the minimum probe diameter of the microscope. Electron energy loss spectroscopy tends to be complimentary to EDS in that it can be used to analyse very thin samples of low Z materials.
Acronym: PEELS
(05 Aug 1998)
spectroscopy <procedure> Spectroscopy is the science of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light, this can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating.
(09 Oct 1997)
spectroscopy, fourier transform infrared A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.
(12 Dec 1998)
spectroscopy, mossbauer A spectroscopic technique which uses the mossbauer effect (inelastic scattering of gamma radiation resulting from interaction with heavy nuclei) to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.
(12 Dec 1998)
spectroscopy, near-infrared A noninvasive technique that uses the differential absorption properties of haemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional haemodynamics and blood flow. Near-infrared light (nir) can propagate through tissues and at particular wavelengths is differentially absorbed by oxgenated vs. Deoxygenated forms of haemoglobin and myoglobin. Illumination of intact tissue with nir allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.
(12 Dec 1998)
infrared spectroscopy The study of the specific absorption in the infrared region of the electromagnetic spectrum; used in the study of the chemical bonds within molecules.
(05 Mar 2000)
electron spin resonance spectroscopy <radiology> A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons.
The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. electron nuclear double resonance (endor) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications.
(12 Dec 1998)
Energy Dispersive Spectroscopy <technique> A microanalytical technique that is based on the characteristic X-ray peaks that are generated when the high energy beam of the electron microscope interacts with the specimen.
Each element yields a characteristic spectral fingerprint that may be used to identify the presence of that element within the sample. The relative intensities of the spectral peaks may be used to determine the relative concentrations of each element in the specimen.
The X-ray signal is detected by a solid-state silicon-lithium detector and the construction and efficiency of this detector sets a lower limit on the atomic number that may be detected. Generally elements heavier than carbon (Z=5) are detectable.
Acronym: EDS
(05 Aug 1998)
Addison's clinical planes A series of plane's used as landmarks in thoracoabdominal topography; the trunk is divided vertically by a median plane from the upper border of the manubrium of the sternum to the pubic symphysis, by a lateral plane drawn vertically on either side through a point half way between the anterior superior iliac spine and the median plane at the interspinal plane, and by an interspinal plane passing vertically through the anterior superior iliac spine on either side; transversely the trunk is divided by a transthoracic plane passing across the thorax 3.2 cm above the lower border of the body of the sternum, by a transpyloric plane midway between the jugular notch of the sternum and the pubic symphysis, corresponding to the disc between the first and second lumbar vertebrae, and by an intertubercular plane passing through the iliac tubercles and cutting usually the fifth lumbar vertebra; the plane's formed on these lines, and also on transverse plane's cutting the upper edge of the manubrium and the upper edge of the pubic symphysis, constitute the clinical plane's of Addison.
(05 Mar 2000)
pathology, clinical A subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids.
(12 Dec 1998)
chemistry, clinical The specialty of analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.
(12 Dec 1998)
pharmacology, clinical The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.
(12 Dec 1998)
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • spectroscopy
    ºÐ±¤ÇÐ
  • clinical
    ÀÓ»óÀÇ
  • clinical
    ÀÓ»óÀÇ;º´»óÀÇ;º´½Ç¿ëÀÇ;(ÆÇ´Ü.¹¦»çµîÀÌ ±Øµµ·Î)°´°üÀûÀÎ;ºÐ¼®ÀûÀÎ;³ÃÁ¤ÇÑ;º´»ó(ÀÓÁ¾)ÀÇ (¼¼·Ê);~ly ÀÓ»óÀûÀ¸·Î
  • clinical death
    ÀÓ»ó»ç(±â±â¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í ÀÓ»óÀû °üÂû·Î ÆÇ´ÜÇÑ Á×À½)
  • clinical ecologist
    ÀÓ»ó »ýÅÂÇÐÀÚ
  • clinical ecology
    ÀÓ»ó »ýÅÂÇÐ
  • clinical pathology
    ÀÓ»ó º´¸®ÇÐ
  • clinical pharmacology
    ÀÓ»ó ¾àÇÐ
  • clinical psychology
    ÀÓ»ó ½É¸®ÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á